PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells

The activation and regulation of target genes by the tumour-suppressor p53 dictates the fate of a cell, with cell cycle arrest or apoptosis being two distinct outcomes. PERP (p53 apoptosis effector related to PMP-22), a p53 transcriptional target, is induced specifically during apoptosis but not cell cycle arrest. Downregulation of PERP is associated with the aggressive, monosomy 3-type of uveal melanoma (UM), the most common primary intraocular tumour in adults, and increased PERP expression has a pro-apoptotic effect in UM cells. Here, we identify a novel effect of PERP expression, as elevated PERP protein positively influences active levels of its own transcriptional regulator, p53. Using fluorescent fusion proteins of PERP, p53 and MDM2, we demonstrate in single living UM cells that PERP expression significantly enhances p53 activity and its nuclear localization, increases p53-dependent transcription (including that of MDM2) while allowing oscillatory nucleo-cytoplasmic shuttling of p53/MDM2 complexes. Phosphorylation of p53 serine residues that interfere with the interaction between p53 and its negative regulator MDM2 and enhance pro-apoptotic gene transcription also occurs subsequent to PERP expression. These results implicate a role for PERP in amplifying functional p53 levels that promote p53-dependent apoptosis, and reveal a potential target for exploitation in enhancing p53 activity.

[1]  Young Sun,et al.  Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma. , 2005, Investigative ophthalmology & visual science.

[2]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[3]  U. Weidle,et al.  Identification of THW, a putative new tumor suppressor gene. , 2000, Anticancer research.

[4]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[5]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[6]  K. Sakaguchi,et al.  Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.

[7]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[8]  E. Stavridi,et al.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Levine,et al.  The P53 pathway: what questions remain to be explored? , 2006, Cell Death and Differentiation.

[10]  P. Giannakakou,et al.  The importance of p53 location: nuclear or cytoplasmic zip code? , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[11]  L. Mayo,et al.  Phosphorylation of Human p53 at Serine 46 Determines Promoter Selection and whether Apoptosis Is Attenuated or Amplified* , 2005, Journal of Biological Chemistry.

[12]  U. Moll,et al.  Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Kishore,et al.  p53 gene and cell cycling in uveal melanoma. , 1996, American journal of ophthalmology.

[14]  B. Ksander,et al.  Melanomas that develop within the eye inhibit lymphocyte proliferation , 1997, International journal of cancer.

[15]  I. Grierson,et al.  Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. , 2006, Experimental eye research.

[16]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.

[17]  M. Hammerschmidt,et al.  Perp is required for tissue-specific cell survival during zebrafish development , 2005, Cell Death and Differentiation.

[18]  G. Kroemer,et al.  Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope , 2005, The Journal of experimental medicine.

[19]  F. Mancini,et al.  MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. , 2007, Molecular cell.

[20]  Y Taya,et al.  DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization , 1999, The EMBO journal.

[21]  D. Spiller,et al.  P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma , 2009, Journal of cellular and molecular medicine.

[22]  B. Padanilam,et al.  PERP, a p53 proapoptotic target, mediates apoptotic cell death in renal ischemia. , 2009, American journal of physiology. Renal physiology.

[23]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[24]  S. Lowe,et al.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. , 2000, Genes & development.

[25]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[26]  G. Borsani,et al.  p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. , 1995, The American journal of pathology.

[27]  J. Harbour,et al.  Deregulation of the Rb and p53 pathways in uveal melanoma. , 2000, American Journal of Pathology.

[28]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[29]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[30]  D. Lane,et al.  Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. , 2001, Experimental cell research.

[31]  A. Levine,et al.  Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[33]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[34]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[35]  K. Vousden.  Outcomes of p53 activation - spoilt for choice , 2006, Journal of Cell Science.

[36]  Rebecca A. Ihrie,et al.  Perp Is a Mediator of p53-Dependent Apoptosis in Diverse Cell Types , 2003, Current Biology.

[37]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .

[38]  K. Vousden,et al.  Complicating the complexity of p53. , 2005, Carcinogenesis.

[39]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[40]  E. Appella,et al.  Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.

[41]  Giulia Piaggio,et al.  Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.